<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) and the GCB subtype of diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) derive from germinal center B cells </plain></SENT>
<SENT sid="1" pm="."><plain>Targeted resequencing studies have revealed mutations in various genes encoding proteins in the NF-kappaB pathway that contribute to the activated B-cell (ABC) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> subtype, but thus far few GCB-specific mutations have been identified </plain></SENT>
<SENT sid="2" pm="."><plain>Here we report recurrent <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> affecting the polycomb-group oncogene EZH2, which encodes a <z:chebi fb="0" ids="15358">histone</z:chebi> methyltransferase responsible for trimethylating Lys27 of <z:chebi fb="0" ids="15358">histone</z:chebi> H3 (H3K27) </plain></SENT>
<SENT sid="3" pm="."><plain>After the recent discovery of mutations in KDM6A (UTX), which encodes the <z:chebi fb="0" ids="15358">histone</z:chebi> H3K27me3 demethylase UTX, in several <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types, EZH2 is the second <z:chebi fb="0" ids="15358">histone</z:chebi> methyltransferase gene found to be mutated in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>These mutations, which result in the replacement of a single tyrosine in the SET domain of the EZH2 protein (Tyr641), occur in 21.7% of <z:e sem="disease" ids="C1333295" disease_type="Neoplastic Process" abbrv="">GCB DLBCLs</z:e> and 7.2% of FLs and are absent from <z:e sem="disease" ids="C1333296" disease_type="Neoplastic Process" abbrv="">ABC DLBCLs</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Our data are consistent with the notion that EZH2 proteins with mutant Tyr641 have reduced enzymatic activity in vitro </plain></SENT>
</text></document>